Kinetics Medical Fund Class A (KRXAX)

33.46
Net Asset Value
+1.36%
1 Day
+12.62%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
5.75
Sales Expenses
2.27%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund normally invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Performance

1 month+3.05% 3 years+27.74%
3 months+3.98% 5 years+19.46%
1 year+24.54% Since inception+6.95%
Data through --

Peer Comparisonvs. Health

 KRXAXCategory
Performance 5-yr return+19.46%+22.35%
Expense ratio2.27%1.42%
Risk 5 year sharpe ratio1.081.48
Net assets$28.8M$3.7B
Average market cap$32.8B$35.4B
Average P/E29.424.6
Portfolio turnover3%3%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyKinetics
Fund manager & tenureBruce Abel / 15 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock66.64%
International stock33.29%
Fixed income0.08%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.65%
Industrial materials 4.23%
Business service 1.12%
Telecommunication 0.01%
Consumer goods 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen9.32%
BMY Bristol-Myers Squibb7.60%
-- 7.24%
NVS Novartis6.32%
LLY Eli Lilly and Co6.01%
ALKS Alkermes Plc5.54%
JNJ Johnson & Johnson5.54%
PFE Pfizer5.43%
SHPG Shire4.83%
SNY Sanofi4.49%

To view my watchlist

Not a member yet?

Sign up now for a free account